Frank X. Leonard, EVP, President, Novocure Oncology at NovoCure Ltd (NVCR), sold 2,527 shares at $18.54 ($47K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal sale ($47k) by EVP, President, Novocure Oncology — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-03 | $552K | — | Filing → |